FDA recall D-886-2013

Product

Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle, Manufactured by: Fabrique par Sanofi-Aventis Canada Inc., Laval, Quebec, Canada H7L4A8, DIN # 02091887

Reason for recall

Subpotent Drug: During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment.

Distribution

Canada

Key facts

Status

Terminated

Initiation date

2013-02-26

Report date

2013-08-21

Termination date

2014-06-06

Voluntary/Mandated

Voluntary: Firm initiated

Location

Laval, Canada

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-886-2013